Last10K.com

Ablynx Nv (ABLX) SEC Filing 6-K Foreign Issuer report for the period ending Tuesday, March 27, 2018

Ablynx Nv

HISTORY TOOLS
CIK: 1617582 Ticker: ABLX

View differences made from one to another to evaluate Ablynx Nv's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 6-K Foreign Issuer Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Ablynx Nv.

Continue

Assess how Ablynx Nv's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Ablynx Nv's Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Material Contracts, Statements, Certifications & more

Ablynx Nv provided additional information to their SEC Filing as exhibits

Exhibit 99.1: Additional Exhibits
Ticker: ABLX
CIK: 1617582
Form Type: 6-K Foreign Issuer Report
Accession Number: 0001193125-18-097668
Submitted to the SEC: Tue Mar 27 2018 4:05:56 PM EST
Accepted by the SEC: Tue Mar 27 2018
Period: Tuesday, March 27, 2018
Industry: Biological Products No Disgnostic Substances

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/ablx/0001193125-18-097668.htm